Recursion Pharmaceuticals (NASDAQ:RXRX) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS
Recursion Pharmaceuticals (NASDAQ:RXRX – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.34) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.01), Briefing.com reports. The company had revenue of $26.08 million for the quarter, compared to analyst estimates of $12.62 million. Recursion Pharmaceuticals had a negative net […]
More Stories
FBI Official Says 449 Alleged Child Predators Arrested in 2 Operations
By Jack Phillips FBI Deputy Director Dan Bongino said this week that 449 child sexual predators were arrested and more...
Rugby Star Turned NFL Wide Receiver Says He Has ‘One to Two More Years’ to Achieve NFL Dream
By John Rigolizzo Jacksonville Jaguars wide receiver and former rugby union star Jacob Rees-Zammit set a hard deadline for his...
Key Takeaways From Trump’s Whirlwind NATO Summit
By Emel Akan THE HAGUE, Netherlands—President Donald Trump wrapped up a whirlwind 24-hour visit to the Netherlands on June 25...
FedEx Lowers Earnings Outlook as Volume From China ‘Deteriorated Sharply’
By Panos Mourdoukoutas FedEx reported another quarter of lackluster sales, as volume from China to the United States fell sharply...
New-Car Sales Numbers Go Up in June: JD Power Report
By Naveen Athrappully Total new-vehicle sales for June 2025, including retail and non-retail transactions, increased 2.5 percent annually, according to...
Gabbard Says ‘New Intelligence’ Shows Iran Nuclear Facilities Destroyed
By Jack Phillips Director of National Intelligence Tulsi Gabbard said on Wednesday that new intelligence has shown that U.S. strikes...